Donate For Public and Patients Store Search

F096 - Myth Busters: A Critical Evaluation of the Evidence Behind Common Cosmetic Recommendations

Sunday, March 3; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe common cosmetic myths
  • Design treatments that are evidence based
  • Distinguish between dogma and data


This session will cover common recommendations in cosmetic dermatology, including pre and post treatment recommendations. We will critically evaluate the evidence behind these approaches. What is known or unknown? Topics will include neuromodulators, fillers, and laser and energy-based therapies. We will review the evidence behind sunscreens, supplements, and cosmeceuticals. Legal myths will be covered. We seek to answer the question: "What's the false?"


  • Anderson, Richard Rox, MD: AVAVA, LLC – B(ST); Blossom Innovations, LLC – B(ST); Cytrellis Biosystems, Inc – C(SO); Massachusetts General Hospital – E(IP); MOE Medical Devices LLC – C(H); Seven Oaks – C(IP); Seventh Sense BioSystems – C(SO); Sofregen Medical, Inc. – C(SO);
  • Avram, Mathew M., MD, JD: Alastin Skincare, Inc – C(Fees); Allergan, Inc – C(Fees); Cytrellis Biosystems, Inc – C(ST); Invasix – C(Fees); Masters of Aesthetics, Inc. – F(Fees); Merz Aesthetics – C(Fees); Sciton Inc. – A(Fees); Sienna Biopharmaceuticals – A(Fees); Zalea, LLC – C(Fees); Zeltiq Aesthetics – C(Fees);
  • Beddingfield, Frederick III, MD: Sienna Biopharmaceuticals – E(S), F(S), SH(ST);
  • Jones, Derek H., MD: Allergan, Inc. – A(H), C(H), I(Grants/Research Funding), SP(H); Evolus, Inc. – I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); Kythera – C(H), I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H), I(Grants/Research Funding), SP(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding);
  • Manstein, Dieter, MD, PhD: AVAVA, LLC – C(H); Blossom Innovations, LLC – SH(ST); Cynosure, Inc. – O(IP); Everbloom LLC – F(ST); GME German Medical Engineering GmbH – SH(ST); Lumenis – A(H), I(Grants/Research Funding); R2 Dermatology, Inc. – C(Fees); Syneron Candela – O(IP); Zalea, LLC – SH(ST); Zeltiq Aesthetics – A(Fees), C(Fees), O(IP);
  • Ross, E. Victor Jr., MD: Candela Corporation – A(Grants/Research Funding), I(H); Cutera, Inc. – I(EQ), I(Grants/Research Funding); Lumenis – I(EQ), I(H); Sebcaia, Inc – A(H); Syneron, Inc. – I(Grants/Research Funding);
  • Sakamoto, Fernanda H., MD: AVAVA, LLC – A(IP); Blossom Innovations, LLC – F(IP); Cytrellis Biosystems, Inc – A(SO); Follica – A(SO); Living Proof, Inc – C(Fees); MOE Medical Devices LLC – A(ST); NexGen Jane – A(ST); Olivio Laboratories, LLC – C(SO); Quanta System S.p.A – A(NC); R2 Dermatology, Inc. – A(ST); Seven Oaks – O(IP); Seventh Sense BioSystems – A(ST); Sofregen Medical, Inc. – A(ST); STGS Innovations – A(ST); Strata Skin Sciences – A(ST);
  • Wanner, Molly, MD: Nuskin – A(Fees), C(Fees), I(Fees);
Sunday, March 3
1:00 PM
Dr. Anderson / Laser and Energy Device Myths Part I: What’s the False?
1:15 PM
Dr. Manstein / Laser and Energy Device Myths Part II: What’s the False?
1:25 PM
Dr. Ross / Laser and Energy Device Myths: Treating patients with Fitzpatrick IV-VI skin in sunny climates. What’s the False?
1:35 PM
Dr. Avram / Legal Myths in Cosmetic Dermatology: What’s the False?
1:45 PM
Dr. Ross, Dr. Avram, and Dr. Anderson / Q&A
2:00 PM
Dr. Beddingfield / Botulinum and Filler Myths Part I: What's the False?
2:15 PM
Dr. Jones / Botulinum and Filler Myths Part II: What's the False?
2:30 PM
Dr. Sakamoto / Sunscreens and Supplements: What’s the False?
2:40 PM
Dr. Wanner / Cosmeceuticals: What’s the False?
2:50 PM
All faculty / Q&A
Event Details
  • Date
    Sunday, March 3
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 209A
  • CME Credits
  • Type
  • Molly Wanner, MD, FAAD
  • Derek H. Jones, MD, FAAD
  • Dieter Manstein, MD, PhD
  • E. Victor Ross Jr., MD, FAAD
  • Fernanda H. Sakamoto, MD
  • Frederick Beddingfield III, MD, FAAD
  • Mathew M. Avram, MD, JD, FAAD
  • Richard Rox Anderson, MD, FAAD